EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Porton Pharma Solutions and Codexis Launch Global Partnership
PARTNERSHIP
Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing business The partnership will accelerate the creation and commercialization of new lowcost sustainable manufacturing processes exploiting the benefits of...
Articles
Role of Nutraceutical in Various Diseases - A Review
DeFelice introduced the term nutraceutical in combining the words nutrition and pharmacy and originally defined it as a food or part of a food that provides medical or health benefits including the prevention and treatment of disease A nutraceutical may be a nutrientdense food like spirulina garlic or soy or a specific dietary component
Research Insights
The Promises Of Quantitative Systems Pharmacology Modelling For Drug Development
Abstract Recent growth in annual new therapeutic entity NTE approvals by the US Food and Drug Administration FDA suggests a positive trend in current research and development RD output Prior to this the cost of each NTE was considered to be rising exponentially with compound failure occurring mainly in clinical phases Quantitative Systems Pharma
Case Studies
Tablet Coating at Low Bed Temperatures with a Novel Coating Polymer
This study shows how to obtain elegant uniform coatings with zero visible defects and a practical coating solution for heat sensitive products For More Infromation Click Here
Techno Trends
RefleXion Medical Developed First-of-its-Kind SCINTIX Biology-guided Radiotherapy
RefleXion Medical has achieved a significant milestone by successfully treating a patient using groundbreaking SCINTIX biologyguided radiotherapy
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Applying Human Factors Engineering to Generic Combination Products
Frauke Schuurkamp has 12 years of experience delivering HFE services to the medical and pharmaceutical industries. Schuurkamp conducts HFE workshops, advises on HFE strategies, leads research and analysis activities and develops key deliverables to support FDA and international regulatory submissions. Schuurkamp holds a bachelor’s degree in applied psychology and a master’s degree in human factors psychology.
Lisanne de Vogel has 7+ years of experience delivering HFE services to the medical device and pharmaceutical industries. Lisanne leads and oversees human factors research activities, such as usability testing, and helps clients develop key HFE documents for their (international) regulatory submissions, as well as advising them on how to apply HFE during product development to meet regulators' expectations. She holds a bachelor’s degree in Communication Science and a master’s degree in Applied Cognitive Psychology.
Pharma Regulatory Bottlenecks and Vaccination Delays
Sonam Chandwani is the Managing Partner at KS Legal & Associates. Her experience encompasses commercial and crosses border transactions across various sectors, advising both Indian companies in their outbound investments and foreign companies investing in India, on diverse areas of Indian laws concerning Mergers & Acquisitions, Insolvency & Bankruptcy, Banking & Finance, Real Estate, Arbitration and Litigation in Courts and Tribunals on a PAN-India basis.
Automation in Pharmaceutical Sector by Implementation of Artificial Intelligence
Amol Shinde is Assistant Manager in Department of Medical Affairs and Pharmacovigilance at Unichem Laboratories Ltd., India with approx. 7 years of working experience in various corporate of pharma industries. He has published 4 papers in international and national journals.
Chemistry & AI
Dr. Ashok Kumar FRSC, President of the Centre for Research & Development at Ipca, earned his PhD from CDRI with Dr. Nityanand and post-doctoral experience from Sussex University with Nobel Laureate Prof. Cornforth. His interests include Chemical, Biotechnological & NDDR research and also integrating spirituality, philosophy, and common sense in his professional and personal life.
Evolution of eCTD from version 1 to 4
Gouspasha is a seasoned professional with 12 years of experience in the pharmaceutical industry, specializing in eCTD (Electronic Common Technical Document) publishing and submission. With a strong focus on regulatory compliance and efficient document management, Gouspasha ensures seamless and timely submissions. Dedicated to maintaining the highest standards of quality and accuracy, Gouspasha remains committed to staying current with evo0lving industry trends and regulatory requirements.
press releasesRead more...
Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Pre-filled Syringe Across Europe
Samsung Bioepis Co Ltd today announced the launch of OPUVIZ mgmL solution in prefilled syringe PFS a biosimilar referencing Eylea aflibercept across Europe starting today
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
Akeso Inc HK Akeso or the Company today announced that the first patient has been dosed in a Phase II clinical study AKD evaluating AKD the Companys internally developed TROPNectin
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
Swedish Orphan Biovitrum AB publ Sobi and Innate Pharma SA Euronext Paris IPH Nasdaq IPHA Innate or the Company today announced that they have entered a strategic partnership to enable initiation
Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension
Nicox SA Euronext Growth Paris FR ALCOX an international ophthalmology company today announced that its exclusive licensee in China Ocumension Therapeutics has submitted the New Drug Application
Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases
Mediar Therapeutics Inc a clinicalstage biotechnology company pioneering firstinclass therapies to halt and reverse fibrosis has entered into a collaboration and option agreement with Ono Pharmaceutical Co
Chugai and UCSF Establish Master Collaboration Agreement for Drug Discovery Research - A Framework to Streamline Future Research Projects-
Chugai Pharmaceutical Co Ltd TOKYO hereafter Chugai and the University of California San Francisco UCSF have entered into a Master Collaboration Agreement to advance drug discovery research
EventsRead more...
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Singapore Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
LATEST NEWSRead more...
Innovent Biologics and Daiichi Sankyo Sign Exclusive China Commercialisation Agreement for VANFLYTA®
Innovent Biologics and Daiichi Sankyo have entered into an exclusive agreement for the commercialisation of VANFLYTA quizartinib in China
Argenx Launches Tender Offer to Acquire Forte Biosciences
Argenx has commenced a tender offer to acquire all outstanding shares of Forte Biosciences through its wholly owned subsidiary Avena Merger Sub Inc The offer values Fortes common shares at US per
GenScript and Tamarind Bio partner to link AI molecular design with wet-lab validation
GenScript Biotech Corporation and Tamarind Bio have entered into a strategic partnership to combine AIpowered molecular design with rapid wetlab validation aiming to streamline the drug discovery process
Phylo and Chugai collaborate to deploy AI platform for drug discovery
Phylo has entered into a collaboration with Chugai Pharmaceutical to deploy Biomni Lab its agentic AI platform for biomedical research across Chugais drug discovery programmes
Amplia Enters into Collaboration with Lilly to Evaluate Narmafotinib in Lung Cancer Trial
Amplia Therapeutics has entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to evaluate its investigational focal adhesion kinase FAK inhibitor narmafotinib
Fujifilm and Taiho Pharmaceutical Partner to Advance Next-Generation ADC Manufacturing
FUJIFILM and Taiho Pharmaceutical have formed a strategic partnership to develop manufacturing technologies for nextgeneration antibodydrug conjugates ADCs